[Frequency of cancer at older ages].

abstract：BACKGROUND:Sorafenib is the standard treatment for advanced hepatocellular carcinoma (HCC). Due to its peculiar toxicities, improving patient's tolerance may need close follow-up. Nurses can play a crucial role, by driving a patient education program (EP). We aimed to prove that adding EP to usual care (UC) improves pa...

journal_title：Bulletin du cancer

authors： Brunot A,M'Sadek A,Le Roy F,Duval M,Le Sourd S,Ventroux E,Crouzet L,Guillygomarc'h A,Boucher E,Lelievre N,Laguerre B,Edeline J

更新日期：2016-11-01 00:00:00

abstract：:Geriatric oncology represents a novel specialty which can be defined as specific older cancer patients management. It includes a validated geriatric procedure, the comprehensive geriatric assessment, which is the best way of approaching the complex interacting medical problems of frail older patients. Geriatric assess...

journal_title：Bulletin du cancer

authors： Terret C,Gaujard S,Droz JP

更新日期：2003-01-01 00:00:00

abstract：:From 1970 to 1982, 79 cases of nasopharyngeal carcinomas were treated at the Regional Cancer Center of Lille (France). At the term of the study, it appears that patients of Central Europe origin have a rather high risk of NPC (17% of cases, that ethnic population representing about 8% of all superior aerodigestive tra...

journal_title：Bulletin du cancer

authors： Lefebvre JL,Madelain M,Adenis L,Demaille MC,Delobelle A,Demaille A

更新日期：1983-01-01 00:00:00

abstract：:Lung and head and neck cancers result from a multistep process involving activation of oncogenes and inactivation of tumor-suppressor genes. These two processes share common features and molecular players, while their corresponding clinical entities are both triggered by the tobacco carcinogens. In many cases, the mol...

journal_title：Bulletin du cancer

authors： Loriot Y,Mordant P,Fouret P,Deutsch E,Soria JC

更新日期：2009-01-01 00:00:00

abstract：:Since January 1981, 58 patients with postoperative recurrences or inoperable rectal cancer have been included in a trial featuring a neutron boost after an initial series of irradiation given by the classical high energy photon procedure. This group irradiated at the Neutrontherapy Unit in Orléans was compared to a hi...

journal_title：Bulletin du cancer

authors： Breteau N,Destembert B,Favre A,Sabattier R,Schlienger M

更新日期：1986-01-01 00:00:00

abstract：:Treatment of patients with small-cell lung cancer (SCLC) remains disappointing despite high initial complete response rates. The dramatic initial chemosensitivity of tumor cells is frustrated by the early emergence of chemoresistant clonogenic cells, regardless of front line treatments. Although the dose relationship ...

journal_title：Bulletin du cancer

authors： Le Chevalier T,Le Cesne A,Arriagada R

更新日期：1995-01-01 00:00:00

abstract：:Thirty-two patients with high risk melanoma (either primary melanoma of the limbs or trunk, or recurrent melanoma) and clinically disease-free following appropriate surgical treatment were immunized with a vaccinia virus oncolysate made from a pool of 4 human melanoma cell lines. Injections were given id weekly for 3 ...

journal_title：Bulletin du cancer

authors： Doré JF,Portoukalian J,Berthier-Vergnes O,Jacubovich R,Genève J,Bailly M,Lefthériotis E,Weissbrod A,Mayer M

更新日期：1990-01-01 00:00:00

abstract：:Whereas medicine is progressing in illness treatment that used to be incurable, physicians are still faced with treatment failure. Hippocrates used to say: "primum non nocere" [1]. When the patient cannot expect benefit from potentially aggressive care, current or possible treatments have to be challenged to leave jus...

journal_title：Bulletin du cancer

authors： Laude C,Deygas S

更新日期：2009-07-01 00:00:00

abstract：:Targeted therapies, especially monoclonal antibodies, have reached an increasing importance in oncology. High-throughput techniques have allowed the identification of numerous transcripts, proteins, or non-protein antigens, which have generated the concept of immunome. This epitope library constitutes a huge reservoir...

journal_title：Bulletin du cancer

authors： Ceze N,Probst A,Lecomte T,Ohresser M,Paintaud G,Watier H

更新日期：2007-01-01 00:00:00

abstract：:This study is concerning 70 patients (57 female, 13 male) with an epidermoid carcinoma of the anal canal which were treated homogeneously with a combination of an external beam radiation therapy ((45 Gy in 25 fractions of 1.8 Gy for 5 weeks) and a brachytherapy with Iridium wires (15 to 20 Gy delivered to the gross re...

journal_title：Bulletin du cancer

authors： Dubois JB,Azria D,Ychou M

更新日期：2003-12-01 00:00:00

abstract：:The majority of patients with breast cancer can be treated by partial mastectomy and radiation therapy. The choice of the treatment involves the estimation of the risk for intramammary recurrence and the ability to achieve satisfactory cosmetic result. Patient selection in breast conserving therapy is dependent on cli...

journal_title：Bulletin du cancer

authors： Zinzindohoué C,Bobin JY

更新日期：1998-09-01 00:00:00

abstract：:From a series of 89 clinically inflammatory breast cancers, the authors settle a subgroup of tumors, the infiltrative ductal carcinomas with a pleomorphic structure. They have better histological and hormonal prognostic criteria than the other carcinomas, especially the infiltrative ductal carcinomas with an atypical ...

journal_title：Bulletin du cancer

authors： Mauriac L,Wafflart J,Trojani M,Durand M

更新日期：1983-01-01 00:00:00

abstract：:Radiation induced lymphopenia is frequent and can be severe and durable. Although lymphocytes have long been known as highly radiosensitive cells, it is poorly characterized. Radiation-induced lymphopenia seems to affect lymphocyte subpopulations differently and seems to be influenced by radiation modalities. The dept...

journal_title：Bulletin du cancer

authors： Cesaire M,Le Mauff B,Rambeau A,Toutirais O,Thariat J

更新日期：2020-01-01 00:00:00

abstract：:Working people who are diagnosed with cancer must generally stop working, and returning to work after treatment is a very important issue for them. This article investigates the impact of cancer on professional trajectory among working women after a breast cancer diagnosis. We conducted in-depth interviews with 21 wom...

journal_title：Bulletin du cancer

authors： Gallardo L,Rey D,Peretti-Watel P

更新日期：2012-07-01 00:00:00

abstract：:The natural history of breast diseases has changed overtime and successive therapeutic strategies have been adapted accordingly. Recently, biological findings on geno- and phenotypic characteristics of tumor cells offer new basis for the development of treatments that target homogenous and various subtypes of breast c...

journal_title：Bulletin du cancer

authors： Roché H

更新日期：2013-09-01 00:00:00

abstract：:Breast cancer (BC) has the highest incidence rate in women in industrialized countries. Statistically, it is estimated that one out of 10 women will develop BC during her life. Evidence is accumulating for the role of ion channels in the development of cancer. Most studied ion channels in BC are K(+) channels, which a...

journal_title：Bulletin du cancer

authors： Ouadid-Ahidouch H,Dhennin-Duthille I,Gautier M,Sevestre H,Ahidouch A

更新日期：2012-06-01 00:00:00

abstract：:Colorectal cancer (CRC) is the second leading cause of cancer-related mortality in France. Recently, colorectal cancer subtyping consortium (CRCSC) identified 4 consensus molecular subtypes (CMS). CMS1 is enriched for CRC with deficient DNA mismatch repair system (dMMR) and tumors with mutated BRAF. Intriguingly, CMS1...

journal_title：Bulletin du cancer

authors： Cohen R,Cervera P,Svrcek M,Dumont C,Garcia ML,Chibaudel B,de Gramont A,Pocard M,Duval A,Fléjou JF,André T

更新日期：2015-06-01 00:00:00

abstract：:Since 1976 to 1978 inclusive, 465 patients with primary breast cancers underwent whole body analogical scintiscans, 456 numerical scans, and 453 were X-rayed. Ninety per cent received axillary node ablation, 62% presented adenopathies of which a third were capsular ruptures and 54% were T3 and T4. In 53 patients, the ...

journal_title：Bulletin du cancer

authors： Robillard J,Ly Van Hoa,Switzers O,Couette JE,Brune D

更新日期：1987-01-01 00:00:00

abstract：:Seventy-five patients with locally advanced non small cell lung carcinoma were entered in a phase II study combining chemotherapy (vindesine, lomustine, cisplatin and cyclophosphamide) and radical thoracic radiotherapy delivering a total dose of 60-65 Gy. Patients were regularly assessed by radiological and fiberoptic...

journal_title：Bulletin du cancer

authors： Nasr E,Pellae-Cosset B,Arriagada R,Le Chevalier T,Baldeyrou P,Ruffie P,de Cremoux H,Martin M,Tarayre M

更新日期：1992-01-01 00:00:00

abstract：:Improvements have been made recently in the treatment of cancer pain. First of all, this symptom is better recognized and evaluated in cancer patients. Then new therapeutic options have became available in France : tramadol, WHO level II analgesic, for intermediate to severe pain; gabapentine, a new anticonvulsivant d...

journal_title：Bulletin du cancer

authors： Di Palma M,Poulain P,Pichard E

更新日期：2004-01-01 00:00:00

abstract：:The authors report their ultrastructural findings of 36 involved lymph-nodes in Hodgkin's disease (HD), before any treatment. More than 400 tumour cells were studied. An analytical study was carried out on the different aspects presented by the nuclei (uni or multi-lobated); the nucleoli (compact, reticulate or disper...

journal_title：Bulletin du cancer

authors： Diebold J,Reynes M,Marchal G,Tricottet V,Mrena E

更新日期：1986-01-01 00:00:00

abstract：:The evidence that C cell hyperplasia is the precursor of medullary carcinoma in families where this tumour is inherited is very strong. It is suggested that the tumour is the result of at least two mutations, in the families with medullary carcinoma the first of these is genetically determined, and the second is an ac...

journal_title：Bulletin du cancer

authors： Williams ED

更新日期：1984-01-01 00:00:00

abstract：:Bladder tumours are frequent with around 10,000 new cases each year in France. Less than 500 of these cases are not transitional cell carcinoma, the most frequent pathological aspect. The identification of these pathological patterns requires an initial biopsy through transurethral resection. Sarcomatoid, squamous and...

journal_title：Bulletin du cancer

authors： Boyle H,Fléchon A,Droz JP

更新日期：2010-01-01 00:00:00

abstract：:In medical oncology, how can we be sure that the right drug is being administered to the right patient at the right time? The implementation of quality assurance criteria is important in medical oncology, in order to ensure that the patient receives the best treatment safely. There is very little literature about qual...

journal_title：Bulletin du cancer

authors： Digue L,Pedeboscq S

更新日期：2014-05-01 00:00:00

abstract：:Cytogenetic, molecular and phenotyping features of malignant hematologic diseases succeeded in improving their management by a more accurate stratification of patients according to several groups of risk and by providing a rational for targeted therapy. Three major types of treatment (excluding cellular therapy) are c...

journal_title：Bulletin du cancer

authors： Baleydier F,Domenech C,Thomas X

更新日期：2011-08-01 00:00:00

abstract：:The treatment of the advanced ovarian adenocarcinoma, most frequently stage at diagnostic, relies on association of surgery and chemotherapy. The current standard is the association carboplatine-paclitaxel. In spite of this treatment, relapses are frequent, and the prognosis thus remains very reserved. Presently the c...

journal_title：Bulletin du cancer

authors： Lhommé C,Even C,Morice P,Balleyguier C,Petrella M,Gouy S,Uzan C,Duvillard P,Pautier P

更新日期：2009-12-01 00:00:00

abstract：:In recent years, Internet has become an indispensable tool for all types of information. Its importance has increased in medicine and particularly in human malignancies. The data issued by the Internet are many and varied sources ranging from official websites to patient's blogs. HIV infection is an infection highly p...

journal_title：Bulletin du cancer

authors： Cluzeau T,Mounier N

更新日期：2010-10-01 00:00:00

abstract：:Oxaliplatin in combination with 5-fluorouracil/leucovorin (LV5FU) improves the response rate and survival of patients with metastatic colorectal cancer. The objective of the Mosaic study was to evaluate the efficacy of this association in the adjuvant treatment of stage II and III colon cancer. This international stud...

journal_title：Bulletin du cancer

authors： André T,Tournigand C,Achille E,Tubiana-Mathieu N,Lledo G,Raoul Y,Carola E,Flesch M,Muron T,Boutan-Laroze A,Guérin Meyer V,Boaziz C,Maigre M,Ganem G,Mousseau M,Mounedji-Boudiaf L,de Gramont A

更新日期：2006-02-01 00:00:00

abstract：:Treatment of metastatic renal cell carcinoma with interleukin 2 (IL2) remains controversial despite the authorization from the French government for IL2 with the West schedule in this disease. We report herein the study of the Institute Gustave-Roussy of 73 patients, who received from 1989 to 1991 a new schedule of hi...

journal_title：Bulletin du cancer

authors： Escudier B,Farace F,Théodore C,Angevin E,Court B,Couanet D,Dietrich PY,Culine S,Pallardy M,Hercend T

更新日期：1995-04-01 00:00:00

abstract：:Unusual aspect of the development of oxaliplatin was that substantial evidence of its activity was gathered when used in combination with protracted infusion of 5FU combined with leucovorin, preceeding the formal demonstration of its single activity in this disease. Phase II trials in previously treated patients by 5F...

journal_title：Bulletin du cancer

authors： André T,Louvet C,Maindrault-Goebel F,Gramont AD

更新日期：2001-08-01 00:00:00